Dallah Healthcare earns SAR 538.3M in 2025, SAR 116.6 M in Q4

04/03/2026 Argaam Exclusive

Content Summary:

Loading data...

Comments Analysis:

Positive: 0%
Neutral: 0%
Negative: 0%
Comments Summary:Loading data...
Please note that this news summary has been generated using artificial intelligence. It is recommended to review the original sources for complete details and to verify the accuracy of the information.
Dallah Healthcare Co.’s net profit rose to SAR 538.3 million in 2025, versus SAR 471.2 million a year earlier.


Financials (M)

Item 2024 2025 Change‬
Revenues 3,205.73 4,066.89 26.9 %
Gross Income 1,206.84 1,452.34 20.3 %
Operating Income 567.12 645.42 13.8 %
Net Income 471.20 538.27 14.2 %
Average Shares 97.68 101.57 4.0 %
Earnings Per Share before unusual items (Riyals) 4.82 4.66 (3.3 %)
EPS (Riyal) 4.82 5.30 9.9 %

The annual profit growth came as revenue for 2025 rose by 26.9% to SAR 4.06 billion, compared to SAR 3.2 billion a year ago, thanks to higher patient visits.

 

Operating profit also increased by 13.8% (SAR 78 million) in 2025 to SAR 645 million, compared to SAR 567 million in the prior year. Revenues generated from Dallah’s two newly-acquired hospitals jumped to about SAR 572 million from their acquisition on March 23, 2025, through Dec. 31, 2025, making up 66.4% of the full-year hike in Dallah’s 2025 topline.

 

In addition, the company’s share of results from associates rose on a yearly basis by approximately SAR 9 million in 2025.

 

This came as the 2025 losses from the Dallah Al-Khobar Hospital declined by SAR 127 million, or 72.2%, compared to 2024.

 

This growth came despite the company recognizing white land fees in the fourth quarter of 2025 related to the years 2023, 2024, and 2025 at Care Shield Co., amounting to SAR 12 million. It also recorded provisions and adjustments for obsolete inventory and supply penalties at Dallah Pharma Co., totaling SAR 17 million.



Current Quarter Comparison (M)

Compared With The
Item Q4 2024 Q4 2025 Change‬
Revenues 808.76 1,110.44 37.3 %
Gross Income 292.76 398.23 36.0 %
Operating Income 115.40 154.94 34.3 %
Net Income 113.90 116.55 2.3 %
Average Shares 97.68 101.57 4.0 %
Earnings Per Share before unusual items (Riyal) 1.17 1.43 22.9 %
EPS (Riyal) 1.17 1.15 (1.6 %)

Dallah Healthcare’s fourth-quarter net profit grew 2.3% to SAR 116.55 million, from SAR 113.9 million in Q4 2024.

 

Sequentially, however, the three-month bottomline declined 17.9% from SAR 141.9 million in Q3 2025.

 

Total shareholders’ equity, after minority interest, increased to SAR 4.08 billion at the end of 2025, from SAR 3.46 billion a year ago.

 

Attached Document:

 

View more financial results

 

View other reports

Share Price

Dallah Healthcare Co.
105.50
4.90 4.87 %

Dallah Healthcare Co. (DALLAH HEALTH)

More


Financial Ratios
Current
Market Cap (M Riyal) 10,716.17
Enterprise Value (EV) (M Riyal) 14,032.91
Shares Outstanding ((M)) 101.58
EPS ( Riyal) (TTM) 5.30
Book Value (BV) ( Riyal) 40.19
Par Value ( Riyal) 10.00
Recurring P/E 22.62
P/E (TTM) 19.91
Price/book 2.62
Return on Average Assets (%) (TTM) 6.9
Return on Average Equity (%) (TTM) 14.3
EV/adj EBITDA -
EV/Revenues 3.45
more

Kindly, you can view the full report by subscribing to the

The report contains the details of the financial statements, The most important financial indicators, Historical information, Charts, and Forecasts of experts.

Contact Us (+966)-92000-7759

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

Popular Links

Quick Links

Join Us

Argaam.com Copyright © 2026, Argaam Investment, All Rights Reserved
Call Request